MOYES JAY M sold 27.4% of their position (22K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $158.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/16/2026ACC: 0001437749-26-020704
+5K
Net shares
Net buyer
$158.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
27K acquired · 22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27K
Price / share
—
Trade value
—
% of position
50.6%
6/11/2026
53.32K→80.32K
Common Stock
Direct
Shares
−22K
Price / share
$7.22
Trade value
$158.80K
% of position
27.4%
6/12/2026
80.32K→58.32K
Total
Net shares
+5K
Net value
-$158.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | A · Award | +27K | — | — | 50.6% | 53.32K | 80.32K |
| Common Stock Direct | 6/12/2026 | S · Sale | −22K | $7.22 | $158.80K | 27.4% | 80.32K | 58.32K |
| Total | +5K | -$158.80K | ||||||
Derivative Transactions0
No derivative transactions reported